BioXcel Therapeutics (BTAI) Work In Process (2022 - 2025)

BioXcel Therapeutics' Work In Process history runs 4 years deep, the most recent figure standing at $368000.0 for Q4 2025.

• On a quarterly basis, Work In Process changed N/A year-over-year to $368000.0 in Q4 2025; TTM through Dec 2025 was $368000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $368000.0, changed N/A from the prior year.
• Work In Process eased to $368000.0 in Q4 2025 per BTAI's latest filing, from $387000.0 in the prior quarter.
• Across five years, Work In Process topped out at $708000.0 in Q4 2022 and bottomed at $122000.0 in Q3 2022.
• The 4-year median for Work In Process is $395000.0 (2022), against an average of $437125.0.
• Biggest YoY gain for Work In Process was 395.9% in 2023; the steepest drop was 8.05% in 2023.
• Year by year, Work In Process stood at $708000.0 in 2022, then slipped by 8.05% to $651000.0 in 2023, then plunged by 40.55% to $387000.0 in 2024, then decreased by 4.91% to $368000.0 in 2025.
• Per Business Quant, the three latest BTAI Work In Process figures stand at $368000.0 (Q4 2025), $387000.0 (Q2 2024), and $253000.0 (Q1 2024).